Veeva Systems Inc: Form 10-Q for the period ended Jul 31, 2017
Filed with the SEC on Sep 7, 2017 and accepted by EDGAR at Sep 7, 2017, 20:26 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-07-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Cost of revenue | 3 months2017-05-01 to 2017-07-31 | $50.4m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2017-02-01 to 2017-07-31 | $99.3m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2017-05-01 to 2017-07-31 | $116.2m | us-gaap:GrossProfit |
| Gross profit | 6 months2017-02-01 to 2017-07-31 | $225.2m | us-gaap:GrossProfit |
| Research and development | 3 months2017-05-01 to 2017-07-31 | $32.7m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2017-02-01 to 2017-07-31 | $61.0m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2017-05-01 to 2017-07-31 | $36.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2017-02-01 to 2017-07-31 | $74.2m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2017-05-01 to 2017-07-31 | $1.9m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2017-02-01 to 2017-07-31 | $3.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2017-05-01 to 2017-07-31 | $37.8m | us-gaap:NetIncomeLoss |
| Net income | 6 months2017-02-01 to 2017-07-31 | $73.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2017-05-01 to 2017-07-31 | $0.25 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2017-02-01 to 2017-07-31 | $0.48 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2017-05-01 to 2017-07-31 | $0.27 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2017-02-01 to 2017-07-31 | $0.53 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2017-05-01 to 2017-07-31 | 153,778,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2017-02-01 to 2017-07-31 | 153,301,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Capital expenditure | 3 months2017-05-01 to 2017-07-31 | $2.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Capital expenditure | 6 months2017-02-01 to 2017-07-31 | $6.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2017-07-31 | $409.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-07-31 | $833.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2017-07-31 | $1.04bn | us-gaap:Assets |
| Current liabilities | At period end2017-07-31 | $255.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2017-07-31 | $269.3m | us-gaap:Liabilities |
| Shareholders' equity | At period end2017-07-31 | $766.6m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001564590-17-018414. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.